Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1997 Jun;91(2):204–211. doi: 10.1046/j.1365-2567.1997.00241.x

Differential expression of CD32 isoforms following alloactivation of human T cells.

G P Sandilands 1, S A MacPherson 1, E R Burnett 1, A J Russell 1, I Downie 1, R N MacSween 1
PMCID: PMC1363848  PMID: 9227318

Abstract

Receptors for the Fc region of immunoglobulin G (IgG) (Fc gamma Rs) exist in three main forms: membrane bound, soluble and cytoplasmic. The function of cytoplasmic Fc gamma Rs is poorly understood. We have previously demonstrated cytoplasmic Fc gamma RII (cCD32) within most normal human peripheral blood lymphocytes (PBL), including T cells. In this study we have investigated the hypothesis that following lymphocyte activation, up-regulation of cCD32 occurs, resulting in increased expression at the cell surface. Normal PBL were activated in vitro using a two-way mixed lymphocyte reaction (MLR) and expression of CD32 monitored by flow cytometry and by immunoperoxidase staining using specific monoclonal antibodies and aggregated mouse IgG subclasses. Furthermore, we designed oligonucleotide probes specific for the three main isoforms of CD32 and looked for changes in mRNA expression throughout the MLR using an in situ hybridization technique. Increased surface expression of CD32 was found on both activated human T and B lymphocytes, but this was found only in the early stages of the MLR, on days 3 and 4, and was virtually absent by day 7. An inverse relationship between cell surface expression of CD32 and mRNA for the IIb isoforms was noted with strong mRNA expression for IIb isoforms occurring in the later stages of the MLR (days 6-7) when interleukin-2R (IL-2R)-positive T cells were predominant. A soluble IgG binding factor (soluble CD32?) was also detected in the MLR culture supernatant. These observations provide support for the hypothesis that synthesis of IIb isoforms of CD32 occurs following alloantigen activation of human T lymphocytes.

Full text

PDF
210

Images in this article

208Figure 3
on p.208
210Figure 5
on p.210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alevy Y. G., Tucker J., Mohanakumar T. CD32A (Fc gamma RIIa) mRNA expression and regulation in blood monocytes and cell lines. Mol Immunol. 1992 Nov;29(11):1289–1297. doi: 10.1016/0161-5890(92)90165-t. [DOI] [PubMed] [Google Scholar]
  2. Brooks D. G., Qiu W. Q., Luster A. D., Ravetch J. V. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med. 1989 Oct 1;170(4):1369–1385. doi: 10.1084/jem.170.4.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Capel P. J., van de Winkel J. G., van den Herik-Oudijk I. E., Verbeek J. S. Heterogeneity of human IgG Fc receptors. Immunomethods. 1994 Feb;4(1):25–34. doi: 10.1006/immu.1994.1004. [DOI] [PubMed] [Google Scholar]
  4. Farquharson M., Harvie R., McNicol A. M. Detection of messenger RNA using a digoxigenin end labelled oligodeoxynucleotide probe. J Clin Pathol. 1990 May;43(5):424–428. doi: 10.1136/jcp.43.5.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fridman W. H., Bonnerot C., Daeron M., Amigorena S., Teillaud J. L., Sautes C. Structural bases of Fc gamma receptor functions. Immunol Rev. 1992 Feb;125:49–76. doi: 10.1111/j.1600-065x.1992.tb00625.x. [DOI] [PubMed] [Google Scholar]
  6. Fridman W. H. Regulation of B-cell activation and antigen presentation by Fc receptors. Curr Opin Immunol. 1993 Jun;5(3):355–360. doi: 10.1016/0952-7915(93)90053-u. [DOI] [PubMed] [Google Scholar]
  7. Jost C. R., de Goede R., Fransen J. A., Daha M. R., Ginsel L. A. On the origin of the FcRIII (CD16)-containing vesicle population in human neutrophil granulocytes. Eur J Cell Biol. 1991 Apr;54(2):313–321. [PubMed] [Google Scholar]
  8. Lanier L. L., Kipps T. J., Phillips J. H. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J Exp Med. 1985 Dec 1;162(6):2089–2106. doi: 10.1084/jem.162.6.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mantzioris B. X., Berger M. F., Sewell W., Zola H. Expression of the Fc receptor for IgG (Fc gamma RII/CDw32) by human circulating T and B lymphocytes. J Immunol. 1993 Jun 1;150(11):5175–5184. [PubMed] [Google Scholar]
  10. Mellman I., Plutner H., Ukkonen P. Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody: possible role of a prelysosomal compartment. J Cell Biol. 1984 Apr;98(4):1163–1169. doi: 10.1083/jcb.98.4.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ravetch J. V., Kinet J. P. Fc receptors. Annu Rev Immunol. 1991;9:457–492. doi: 10.1146/annurev.iy.09.040191.002325. [DOI] [PubMed] [Google Scholar]
  12. Sandilands G. P., McLaren A. P., Howie D., MacSween R. N. Occult expression of CD32 (Fc gamma RII) in normal human peripheral blood mononuclear cells. Immunology. 1995 Dec;86(4):525–532. [PMC free article] [PubMed] [Google Scholar]
  13. de Bustros A., Baylin S. B., Berger C. L., Roos B. A., Leong S. S., Nelkin B. D. Phorbol esters increase calcitonin gene transcription and decrease c-myc mRNA levels in cultured human medullary thyroid carcinoma. J Biol Chem. 1985 Jan 10;260(1):98–104. [PubMed] [Google Scholar]
  14. van de Winkel J. G., Anderson C. L. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol. 1991 May;49(5):511–524. doi: 10.1002/jlb.49.5.511. [DOI] [PubMed] [Google Scholar]
  15. van de Winkel J. G., Capel P. J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today. 1993 May;14(5):215–221. doi: 10.1016/0167-5699(93)90166-I. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES